Lumos Pharma, Inc.
LUMO · NASDAQ
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$34,034 | -$31,062 | -$30,430 | -$5,663 |
| Dep. & Amort. | $44 | $49 | $203 | $584 |
| Deferred Tax | $0 | $0 | $0 | -$9,500 |
| Stock-Based Comp. | $2,322 | $2,320 | $2,879 | $1,074 |
| Change in WC | $965 | $2,096 | -$2,314 | -$3,618 |
| Other Non-Cash | -$392 | -$26 | $14 | -$5,874 |
| Operating Cash Flow | -$31,095 | -$26,623 | -$29,648 | -$22,997 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | -$21 | -$30 | -$30 |
| Net Acquisitions | $0 | $0 | $0 | $84,179 |
| Inv. Purchases | -$7,378 | -$11,337 | $0 | $0 |
| Inv. Sales/Matur. | $18,120 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | -$11,337 | $26,000 | $32,500 |
| Investing Cash Flow | $10,742 | -$11,358 | $25,970 | $116,649 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | -$27 |
| Stock Issued | $725 | $0 | -$78 | $116,949 |
| Stock Repurch. | -$1,310 | -$675 | -$114 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $9 | -$146 | -$114 | $102 |
| Financing Cash Flow | -$576 | -$821 | -$192 | $75 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$20,929 | -$38,802 | -$3,870 | $93,727 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $56,007 | $94,809 | $98,679 | $4,952 |
| End Cash | $35,078 | $56,007 | $94,809 | $98,679 |
| Free Cash Flow | -$31,095 | -$26,644 | -$29,678 | -$23,027 |